Rallybio Corporation Announces Executive Changes
The Board of Directors of Rallybio Corporation made an announcement on June 28, 2023. They stated that Dr. Mackay, who has been the CEO and Chairman of the Board since 2018, will now be taking on the role of Executive Chairman starting from August 1, 2023. In his new position, Dr. Mackay will continue to work full-time for Rallybio and will be actively involved in company strategy, investor relations, and other related activities. Additionally, the Board decided to expand its size from ten directors to eleven directors, effective from August 1, 2023. Dr. Uden has been appointed as a new director to fill this newly created position.
Dr. Uden has been appointed as a Class II director at Rallybio and will hold this position until the company's annual meeting of shareholders in 2026. It is important to note that Dr. Uden will not be receiving extra payment for his role as a director. For more details about Dr. Uden's background, you can refer to his biography provided in Rallybio's official Proxy Statement for the 2023 annual meeting of shareholders. This statement was submitted to the Securities and Exchange Commission on April 10, 2023.
